April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Phaconeedling versus phaco-retrabeculectomy in the treatment of patients with concomitant cataract and failed trabeculectomy
Author Affiliations & Notes
  • Leonardo Seidi Shigueoka
    Glaucoma, University of Campinas, Campinas, Brazil
  • Jose Paulo C Vasconcellos
    Glaucoma, University of Campinas, Campinas, Brazil
  • Vital P Costa
    Glaucoma, University of Campinas, Campinas, Brazil
  • Footnotes
    Commercial Relationships Leonardo Shigueoka, None; Jose Paulo Vasconcellos, None; Vital Costa, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3156. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Leonardo Seidi Shigueoka, Jose Paulo C Vasconcellos, Vital P Costa; Phaconeedling versus phaco-retrabeculectomy in the treatment of patients with concomitant cataract and failed trabeculectomy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3156.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Combined cataract/glaucoma surgery is indicated in eyes with cataract and a failed trabeculectomy. IOP control following a failed trabeculectomy may be achieved with a needling procedure or a repeat trabeculectomy. The purpose of this study was to compare the efficacy and safety of phacoemulsification and needling with mytomicin C (phaconeedling) or phacoemulsification and a second trabeculectomy with mytomicin C (phaco-retrabeculectomy) in patients with cataract and a failed trabeculectomy.

Methods: A retrospective, nonrandomized and comparative study of 22 eyes of 22 patients who underwent phaconeedling (n=10) or phaco-retrabeculectomy (n=12). Postoperative outcome measures included change in visual acuity (VA), intraocular pressure (IOP), the number of antiglaucoma medications, and postoperative complications.

Results: There were no differences in age, sex, ethnicity, type of glaucoma or number of previous glaucoma surgeries between the groups (p>0.05). Preoperatively, mean±SD logMAR VA (1.38±0.6 versus 1.22±0.7, p=0.94) and IOP (15.75±5.2 versus 16.84±6.8, p=0.66) were similar, but the number of anti-glaucoma medications was significantly higher for phaco-retrabeculectomy group (3.08±0.7 versus 3.81±0.7, p=0.03). Patients were followed for a mean of 6.18±4.3 months (range: 2 to 12 months). After 6 months, mean IOPs in the phaconeedling and phaco-retrabeculectomy were 9.66±3.5 mmHg and 14.77±6.83 mmHg, respectively (p=0.25), and the number of antiglaucoma medications were 0.33±0.5 and 1.00±1.3, respectively (p=0.42). There were no significant differences regarding postoperative complications between the groups (p=0.54).

Conclusions: Phaconeedling is an effective and safe surgical option for eyes with cataract and a failed trabeculectomy.

Keywords: 568 intraocular pressure • 445 cataract • 462 clinical (human) or epidemiologic studies: outcomes/complications  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×